FDA's Pazdur Jumps Over To New 'Moonshot' Role
This article was originally published in The Pink Sheet Daily
Executive Summary
Creation of agency's new Oncology Center of Excellence means the Office of Hematology and Oncology Products, often seen as FDA's model product review shop, needs new leadership – at least temporarily.